CoM on the other hand resembles cutaneous melanoma and has driver mutations in BRAF, NRAS, Kit, TERT, or NF1.20–25 Despite their different backgrounds, UM and CoM share the need for the development of new and effective therapies.26 This evidence concerns the gene NRAS and cutaneous melanoma.